Hepatitis and Cancer: Genetic Aspects

References

• Parkin D M, Stjernsward J, Muir C S. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 1984; 62: 163–82
   PubMed Web of Science ®Google Scholar
• Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. Univ International is Contra Cancrum. Berlin: Springer-Verlag. 1966; I
   Google Scholar
• Doll R, Muir C, Waterhouse J. Cancer incidence in five continents. Univ Internationalis Contra Cancrum. Springer Verlag, Berlin 1970; II
   Google Scholar
• Lutwick L I. Relation between aflatoxin and hepatitis-B virus and hepatocellular carcinoma. Lancet 1979; i: 755–7
   Google Scholar
• Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamara T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New Engl J Med 1993; 328: 1797–801
   PubMed Web of Science ®Google Scholar
• Szmuness W. Hepatocellular carcinoma and the hepatitis B virus. Evidence for a causal association. Progress in Medical Virology 1978; 24: 40–69
   PubMedGoogle Scholar
• Tabor E, Gerety R J, Vogel C L, Bayley A C, Anthony P P, Chan C H, Barker L F. Hepatitis B virus infection and primary hepatocellular carinoma. J Ntl Cancer Inst 1977; 58: 1197–200
   PubMed Web of Science ®Google Scholar
• Sakuma K, Takahara T, Okuda K, Tsuda F, Mayumi M. Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study. Gastroenterology 1982; 83: 114–7
   PubMed Web of Science ®Google Scholar
• Hall A J, Winter P D, Wright R. Mortality of hepatitis B positive blood donors in England and Wales. Lancet 1985; i: 91–3
   Google Scholar
• Beasley R P, Hwang L Y, Lin C C, Chien C S. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981; ii: 1129–32
   Google Scholar
• Larouze B, London W T, Saimot G, Werner B G, Lustbader E D, Payet M, Blumberg B S. Host responses to hepatitis B infection in patients with primary hepatic carcinoma and their families. Lancet 1976; ii: 534–8
   Google Scholar
• Stevens C E, Beasley R P, Tsui J. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771–4
   PubMed Web of Science ®Google Scholar
• Kosky R, Maupas P, Möller R, Hofschneider P H. Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J Gen Virol 1981; 57: 95–102
   PubMed Web of Science ®Google Scholar
• Hino O, Kitagwa T, Koike K, Kobayashi M, Hara M, Mori W, et al. Detection of hepatitis B virus DNA in hepatocellular carcinoma in Japan. Hepatology 1984; 4: 90–5
   PubMed Web of Science ®Google Scholar
• Schafritz D A, Shouval D, Sherman H I, Hadziyannis S J, Kew M C. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med 1981; 305: 1067–73
   PubMed Web of Science ®Google Scholar
• Zaman S N, Melia W M, Johnson R D, Portman B C, Johnson P J, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985; i: 1357–9
   Google Scholar
• Arrigoni A, Zago P, Mazzucco D, Andriulli A, Rizzetto M. Cirrhosis and liver cancer. Lancet 1985; ii: 277
   Google Scholar
• Kalayci C, Johnson P J, Davies S E, Williams R. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol 1991; 19: 54–9
   Google Scholar
• Brechot C, Nalpas B, Courouce A M, Duhamel G, Callard P, Carnot F, et al. Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med 1982; 306: 1384–7
   PubMed Web of Science ®Google Scholar
• Resnick R H, Koff R. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. Arch Int Med 1993; 153: 1672–7
   PubMed Web of Science ®Google Scholar
• Blum H E. Does hepatitis C virus cause hepatocellular carcinoma?. Hepatology 1994; 19: 251–8
   PubMed Web of Science ®Google Scholar
• Kaczynski J, Hansson G, Hermodsson S, Olsson R, Wallerstedt S. Minor role of hepatitis B and C infection in etiology of hepatocellular carcinoma in a low endemic area. Scand J Gastroenterol, In press.
   Web of Science ®Google Scholar
• Yamauchi M, Nakahara M, Nakajima H, Hirakawa H, Toda G, Fujisawa K. Close correlation between the rate of mortality due to hepatocellular carcinoma and the carrier rate of HCV, especially HCV genotype II (or 1G). Viral hepatitis and liver disease, K Nishioka, H Suzuki, S Mishiro, T Oda. Springer-Verlag, Berlin 1993; 710–2
   Google Scholar
• Hasan F, Jeffers L J, DeMedina M, Reddy K R, Parker T, Schiff E R, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12: 589–91
   PubMed Web of Science ®Google Scholar
• Dazza M C, Meneses L V, Girard P M, Astagueau P, Villarouel C, Delaporte E, Larouze B. Absence of relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique. Am J Trop Med Hyg 1993; 48: 237–42
   PubMed Web of Science ®Google Scholar
• Srivatanakul P, Parkin D M, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, et al. Liver cancer in Thailand. A case-control study of hepatocellular carcinoma. Int J Cancer 1991; 48: 329–32
   PubMed Web of Science ®Google Scholar
• Takase S, Tsutsumi M, Kawahara H, Takada N, Takada A. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 1993; 17: 9–13
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993; 88: 39–43
   PubMed Web of Science ®Google Scholar
• Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797–801
   PubMed Web of Science ®Google Scholar
• Yu M W, Hsiek H H, Pau W H, Yang C S, Chen C J. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res 1995; 55: 1301–5
   PubMed Web of Science ®Google Scholar
• Lee S D, Lee F H, Wu J C, Hwang H J, Wang S S, Lo K J. The prevalence of anti-HCV among Chinese patients with hepatocellular carcinoma. Cancer 1992; 69: 342–5
   PubMed Web of Science ®Google Scholar
• Leung N WY, Tarn J S, Lai J Y, Leung T WT, Lau W Y, Shiu W, Li A KC. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?. Cancer 1992; 70: 40–4
   PubMed Web of Science ®Google Scholar
• Yuki N, Hayashi N, Kasahara H, Hagiwara H, Katayama K, Fusamoto H, Kamada T. Hepatitis B virus markers and antibody to hepatitis C virus in Japanese patients with hepatocellular carcinoma. Dig Dis Sci 1992; 37: 65–72
   PubMed Web of Science ®Google Scholar
• DiBisceglie A M, Simpson L H, Lotze M I, Hoofnagle J H. Development of hepato-cellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994; 19: 222–6
   PubMed Web of Science ®Google Scholar
• Hasan F, Jeffers L J, DeMedina M, Reddy K R, Parker T, Schiff E R, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12: 589–91
   PubMed Web of Science ®Google Scholar
• Ruiz J, Sangro B, Cuende J I, Beloqui O, Riezu-Bej J I, Herrero J I, Prieto J. Hepatitis Bland C viral infections in patients with hepatocellular carcinoma. Hepatology 1992; 16: 637–41
   PubMed Web of Science ®Google Scholar
• Liang T J, Jeffers L J, Reddy K R, DeMedina M, Paker I T, Cheinqueir H, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993; 18: 1326–33
   PubMed Web of Science ®Google Scholar
• Goritsas C P, Athanasiadou A, Arvaniti A, Lampropoulou, Karatza C. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study. J Clin Gastroenterol 1995; 20: 220–4
   PubMed Web of Science ®Google Scholar
• DeMitri M S, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345: 413–5
   PubMed Web of Science ®Google Scholar
• Gerber M A, Shieh Y SC, Shim K S, Thung S N, Demetris A J, Schwartz M, et al. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol 1992; 141: 1271–7
   PubMed Web of Science ®Google Scholar
• Haruna Y, Hayashi N, Kamada N, Hyflroglou P, Thung S N, Gerber M A. Expression of hepatitis C virus in hepatocellular carcinoma. Cancer 1994; 73: 2253–8
   PubMed Web of Science ®Google Scholar
• Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer incidence in five continents, vol 5 (IARC Scientific Publications, no 88). International Agency for Research on Liver Cancer, Lyon 1987
   Google Scholar
• Parkin D M. Cancer occurrence in developing countries (IARC Scientific Publications, no 75). International Agency for Research on Liver Cancer, Lyon 1986; 27–130
   Google Scholar
• Kew M C, Roussouw E, Hodgkinson J, Paterson A C, Dusheiko G M, Whitcutt M. Hepatitis B virus status in southern African blacks with hepatocellular carcinoma: comparison between rural and urban patients. Hepatology 1983; 3: 65–8
   PubMed Web of Science ®Google Scholar
• Steyn M, Purchase I FH. Symposium on Mycotoxins in Human Health. Pretoria, I FH Purchase. Macmillan, London 1971
   Google Scholar
• Linsell C A. Liver cancer and mycotoxins. Virus associated cancers in Africa, A O Williams, G T O'Conor, G B De-The, C A Johnson. International Agency for Research on Liver Cancer, Lyon 1984; 161–5
   Google Scholar
• Kew M C, Houghton M, Choo Q L, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 873–4
   PubMed Web of Science ®Google Scholar
• Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Chryohji F, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51: 2842–7
   PubMed Web of Science ®Google Scholar
• Chen D S, Kuo G C, Sung J L, Lai M Y, Sheu J C, Chen P J, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162: 817–22
   PubMed Web of Science ®Google Scholar
• Yu M C, Tong M J, Coursaget P, Ross R K, Govindarajan S, Henderson B E. Prevalence of hepatitis B and C markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990; 82: 1038–41
   PubMedGoogle Scholar
• Bruix J, Barrera J M, Calvet X, Ercilla G, Costa J, Sanchez-Tapias J M, et al. Prevalence of antibodies to hepatitis C in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 1004–6
   PubMed Web of Science ®Google Scholar
• Colombo M, Kuo G, Choo Q L, Donato M F, Del Ninno E, Tommasini M A, et al. Prevalence of antibodies to hepatits C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006–8
   PubMed Web of Science ®Google Scholar
• Kaklamani E, Trichopoulos M D, Tzonou A, Zavitsanos X, Küumantaki Y, Hatsakis A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. J Am Med Assoc 1991; 265: 1974–6
   PubMed Web of Science ®Google Scholar